Further Revita results encouraging
Latest results from the makers of Revita, the revolutionary ‘intestine resurfacing’ device being proposed as a treatment for T2D, offer a glimmer of light in
Latest results from the makers of Revita, the revolutionary ‘intestine resurfacing’ device being proposed as a treatment for T2D, offer a glimmer of light in
Fractyl Health has received $100m to help further its new treatment to minimise or eliminate the need for Type 2 diabetes patients to receive insulin